Introduction Erectile dysfunction is associated with diabetes mellitus with an estimated
prevalence of 52.5% in the diabetic population. The first‐line therapy for erectile dysfunction …

Penile concerns include erectile dysfunction (ED) and Peyronie disease (PD). Restorative
therapies including Stem Cell Therapy (SCT) and Platelet Rich Plasma (PRP) injections are …

Erectile dysfunction (ED) is an inability to attain or maintain adequate penile erection for
successful vaginal intercourse, leading to sexual and relationship dissatisfaction. To combat …

Severe acute respiratory syndrome coronavirus-2 and the related coronavirus disease-19
(COVID-19) is a worldwide emerging situation, which was initially reported in December …

Introduction Erectile dysfunction (ED) is a common disease among elderly men, and novel
therapy methods are needed for drug-refractory ED. As an extracellular vesicle, stem cell …

Erectile dysfunction (ED) has been identified as one of the most frequent chronic
complications of diabetes mellitus (DM). The prevalence of ED is estimated to be about …

Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection
sufficient to permit satisfactory sexual performance, causing tremendous effects on both …

Background aims The efficacy of phosphodiesterase type 5 inhibitors (PDE5Is), which are
commonly used to treat erectile dysfunction (ED), is not satisfactory in patients with …

Background: The improvement of absent or partial response in the medical treatment of
erectile dysfunction (ED) has led to the development of minimally invasive new treatment …

Erectile dysfunction (ED) is a common condition which reduces quality of life of both patients
and their partners, and is a significant health care expense every year. Although …